Central Retinal Artery Occlusion: Current Practice, Awareness and Prehospital Delays in Switzerland

Autor: Elena Ardila Jurado, Veit Sturm, Florian Brugger, Krassen Nedeltchev, Marcel Arnold, Leo H. Bonati, Emmanuel Carrera, Patrik Michel, Carlo W. Cereda, Manuel Bolognese, Sylvan Albert, Friedrich Medlin, Christian Berger, Ludwig Schelosky, Susanne Renaud, Julien Niederhauser, Christophe Bonvin, Marie-Luise Mono, Biljana Rodic, Alexander A. Tarnutzer, Guido Schwegler, Stephan Salmen, Andreas R. Luft, Nils Peters, Jochen Vehoff, Georg Kägi, The Swiss Stroke Registry Investigators

Publikováno v: Frontiers in Neurology, Vol 13 (2022)

Background and PurposeCentral retinal artery occlusion (CRAO) often leads to permanent monocular blindness. Hence, early recognition and rapid re-perfusion is of paramount importance. This study aims to describe prehospital pathways in CRAO compared

Externí odkaz: https://doaj.org/article/4cc7b23bf33b472985c6bfcfb1f9621f

Immune checkpoint inhibitor therapy-associated encephalitis: a case series and review of the literature

Autor: Johann Stuby, Thomas Herren, Guido Schwegler Naumburger, Claudia Papet, Alain Rudiger

Publikováno v: Swiss Medical Weekly, Vol 150, Iss 4748 (2020)

BACKGROUND Immune checkpoint inhibitors (ICIs) can cause a wide spectrum of immune-related adverse events, including encephalitis. To date, no prospective randomised controlled trials examining the patient characteristics, treatment and outcomes of

Externí odkaz: https://doaj.org/article/3877a7a4f70949eb94b42c453a84fbb7

Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial.

Autor: Christian P Kamm, Marwan El-Koussy, Sebastian Humpert, Oliver Findling, Yuliya Burren, Guido Schwegler, Filippo Donati, Martin Müller, Felix Müller, Johannes Slotboom, Ludwig Kappos, Yvonne Naegelin, Heinrich P Mattle, SWABIMS Study Group

Publikováno v: PLoS ONE, Vol 9, Iss 1, p e86663 (2014)

Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects.To report the 12-month extension of a phase II trial evaluating the efficacy, safety and tolerability of atorvastatin 40 mg/d added to interferon bet

Externí odkaz: https://doaj.org/article/b9476f2105374dee82c644d0fbeee7f9

Ischemic stroke in COVID-19 patients: Mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis

Autor: Ludwig Schelosky, Valerian L Altersberger, Nils Peters, Christophe Bonvin, Marcel Arnold, Marie-Luise Mono, Stefan T. Engelter, Lehel-Barna Lakatos, Shadi Taheri, Georg Kägi, Giovanni Bianco, Santi Galletta, Andrea von Reding, Carlo W. Cereda, Emmanuel Carrera, Davide Strambo, Manuel Bolognese, Krassen Nedeltchev, Guido Schwegler, Alexander A. Tarnutzer, Florian Lindheimer, Morin Beyeler, Christian Berger, Urs Fischer, Andreas R. Luft, Rolf Sturzenegger, Biljana Rodic, Federico Massini, Gian Marco De Marchis, Leo H. Bonati, Markus Baumgärtner, Patrik Michel, Albert Sylvan, Friedrich Medlin, Pamela N Correia, Timo Kahles, Stephan Salmen

Publikováno v: European journal of neurology, vol. 29, no. 3, pp. 732-743
Strambo, Davide; De Marchis, Gian Marco; Bonati, Leo H; Arnold, Marcel; Carrera, Emmanuel; Galletta, Santi; Nedeltchev, Krassen; Kahles, Timo; Cereda, Carlo W; Bianco, Giovanni; Kägi, Georg; Luft, Andreas R; Bolognese, Manuel; Lakatos, Lehel-Barna; Salmen, Stephan; Correia, Pamela; Sturzenegger, Rolf; Sylvan, Albert; Medlin, Friedrich; Berger, Christian; ... (2022). Ischemic stroke in COVID-19 patients: mechanisms, treatment and outcomes in a consecutive Swiss Stroke Registry analysis. European journal of neurology, 29(3), pp. 732-743. Blackwell Science 10.1111/ene.15199

Most case series of patients with ischemic stroke (IS) and COVID-19 are limited to selected centers or lack 3-month outcomes. The aim of this study was to describe the frequency, clinical and radiological features, and 3-month outcomes of patients wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd0ec4cd39f3a6c42a62ebb831481dbc
https://serval.unil.ch/notice/serval:BIB_F4A71442E1E9

Revascularisation aiguë en cas d’accident vasculaire cérébral ischémique

Autor: Marcel Arnold, Krassen Nedeltchev, Carlo W. Cereda, Christophe Bonvin, David Bervini, Emmanuel Carrera, Georg Kägi, Thomas Nyffeler, Stephan G. Wetzel, Henrik Gensicke, Guido Schwegler, Jean-Daniel Rouvé, Thilman Schubert, Susanne Wegener, Michael Diepers, Pasquale Mordasini, Patrik Michel, Stefan T. Engelter, Yvan Gasche

Publikováno v: Forum Médical Suisse ‒ Swiss Medical Forum.

Lignes directrices suisses revisees de la Societe Cerebrovasculaire Suisse et ses societes partenaires suite aux nouvelles donnees scientifiques.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ba4be886019f7ea94328bdb39526f0f
https://doi.org/10.4414/fms.2021.08584